-
effectivehealthcare-admin.ahrq.gov/products/safety-vaccines/protocol
January 01, 2021 - 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (152174)
("clinical trial" or "clinical trial, phase … i" or "clinical trial, phase ii" or clinical trial, phase iii or clinical trial, phase iv or controlled … randomized controlled trial").pt. or double-blind method/ or clinical trials as topic/ or clinical trials, phase … i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical … trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized controlled trials as
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - Is it transitioning from one phase to another? If so, select.
b. … Is it transitioning from one phase to another? If so, select.
b. … Is it transitioning from one phase to another? If so, select.
b. … for track-only;
interventions with some preliminary phase III or later phase efficacy data are
considered … Phase of Development and Comment
9.
-
effectivehealthcare-admin.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
December 01, 2020 - We also sought prospective phase I or II nonrandomized studies that included patient subgroups with specific … If higher-level studies (RCTs, prospective phase I and II) were not available, case series (single-arm … not assess study quality or the overall strength of the evidence”
During the Topic Refinement phase … There also were a number of prospective phase I and II clinical studies that complemented the RCTs. … validity, we made a decision to compile the RCTs in the evidence map, supplementing them with prospective phase
-
effectivehealthcare-admin.ahrq.gov/products/autism/research-protocol
December 01, 2019 - we revised the key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long term … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare-admin.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
December 01, 2019 - adrenergic agonist
Increases bladder capacity by relaxing the bladdersmooth muscle during the storage phase … random allocation/
double blind method/
single blind method/
clinical trial/
clinical trial, phase … clinical trial, phase ii.pt.
clinical trial, phase iii.pt.
clinical trial, phase iv.pt. … Effects and Adverse Reactions"/
exp Adverse Drug Reaction Reporting Systems/
exp Clinical Trials, Phase … Effects and Adverse Reactions"/
exp Adverse Drug Reaction Reporting Systems/
exp Clinical Trials, Phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the one topic for which (1) preliminary phase III data were available; … These topics were ineligible for consideration in this report because no phase III data were
available
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … priority area this time (among the
11 topics being tracked as of May 18, 2013) for which (1) preliminary phase … The 6-month buprenorphine
implant completed phase III trials, one of which was funded by the National
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0416_02-18-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
January 01, 2008 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0543_05-24-2013.pdf
January 01, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0620_131115.pdf
March 13, 2013 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014-1
August 01, 2019 - After establishing a predictable baseline pattern of data, one examines the data within each phase to … assess the performance and potentially to extrapolate to the next phase. … Assessment involves: (1) level, the mean for the data in a phase; (2) trend, the slope of the line of … best fit in a phase; (3) variability of the data around this line; (4) immediacy of the effect, the … had an effect by changing the outcome from phase to phase.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the two topics for which (1) preliminary phase III data for drugs were … this period, primarily due to failure to meet stated
endpoints or demonstrate treatment efficacy in phase … and two beta-amyloid precursor
protein site–cleaving enzyme (BACE) inhibitors, currently in late-phase … The latter cooperative sponsors the largest ongoing trial, a phase II/III trial
investigating intranasal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the one topic for which (1) preliminary phase III data for drugs were … Phase III trials conducted to
obtain FDA approval reported that patients with SBS treated with teduglutide … Of the 566 subjects, 173 subjects were treated in Phase 3 SBS
studies (134/173 [77%] at the dose of … Phase 3 Gattex (teduglutide) data highlight
potential new treatment for adults with short bowel
syndrome
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the four topics for which (1) preliminary phase III data for drugs or … Recently completed unphased,
phase II, and phase IV clinical studies reported that daily oral zonisamide … In a phase III
trial sponsored by the University of Pittsburgh (Pittsburgh, PA) and its affiliated … , a University of Pittsburgh (Pittsburgh, PA)-based research group reported results
from a larger phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
May 27, 2010 - The reference is:
First results of a phase III multicenter randomized controlled trial of intensity … All three randomized studies, as well as all phase II-like
and retrospective comparisons, report improved … Besides careful phase I-II studies of dose
escalation, a policy of delivering higher doses using IMRT … In addition, two phase III
RTOG trials (0522 and 0234) have 3DRT and IMRT treatment populations which … Besides careful
phase I-II studies of dose escalation, a policy of delivering higher doses using
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase